Evidence mapPaperPMID 23302619Full record

ArticleZhonghua er ke za zhi = Chinese journal of pediatrics2012

[Clinical and pathological features of Denys-Drash syndrome: report of 3 cases].

Hai-yan Wang, Liang-zhong Sun, Zhi-hui Yue, Juan Yang, Xiao-yun Jiang, Ying Mo

Registry-linked trialAbstract readCase ReportsEnglish Abstract
PubMed
In one paragraph

Article in Zhonghua er ke za zhi = Chinese journal of pediatrics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07590219 (Efficacy, Metabolic and Cardiovascular Effects of Liraglutide in Children Aged 6-12 Years With Severe Obesity), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07590219 phase4active not recruitingstarted 2024, after this paper: background citation

Efficacy, Metabolic and Cardiovascular Effects of Liraglutide in Children Aged 6-12 Years With Severe Obesity: A Randomized Controlled Trial With Advanced Echocardiographic Assessment

Ran2024Enrolled30Registered outcomes9Posted comparisons0ConditionsCardiovascular Function, Childhood Obesity, Echocardiography, LiraglutideArmsLiraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml
Open the trial in the graph
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hai-yan WangDepartment of Pediatrics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Liang-zhong Sun
Zhi-hui Yue
Juan Yang
Xiao-yun Jiang
Ying Mo
The First Affiliated Hospital, Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo study the clinical and pathological features of Denys-Drash syndrome (DDS).

methodThree DDS cases who were treated in our department from December 2009 to June 2011 were subjected to this study by reviewing of literature.

resultBoth case 1 and case 2 were female, with karyotype 46, XX. Case 3 was male with bilateral cryptorchidism. The ages of nephropathy onset of the three cases were 1 year and 9 months, 2 years and 8 moths, and 3 months respectively. Proteinuria in case 2 and case 3 were evidenced to be resistant to steroid. Case 1 was partially responsive to tacrolimus, plasma albumin and cholesterol were improved, although proteinuria was persistent after Tacrolimus was administered. Remission was achieved in case 2 after administration of cyclosporine A and later tacrolimus, and her renal function remains normal till present (4 years and 9 months). Residue renal histology revealed diffused mesangial sclerosis (DMS) in all three patients. All of the three patients had developed right unilateral Wilms tumor. A novel WT1 missense mutation exon 9 c.1213C > G was detected in case 1. WT1 exon 9 c.1168C > T nonsense mutation and exon 8 c.1130A > T missense mutation were detected in case 2 and case 3, respectively.

conclusionThe clinical manifestation of nephropathy in DDS is variable. The majority present with early onset nephropathy and reach renal failure before the age of 4 years. But in a few patients, nephropathy can also be present much later and progress slowly. Proteinuria in DDS is resistant to steroid but is responsive to calcineurin inhibitors, including Cyclosporine A. The effectiveness of tacrolimus was also observed in this study. DDS is evidently caused by WT1 mutation. DMS is the characteristic renal pathological change in DDS.

Indexed as

Genes, Wilms TumorMutationCyclosporineDenys-Drash SyndromeFatal OutcomeFemaleHeterozygoteHumansInfantMaleNephrotic SyndromeProteinuriaSclerosisTacrolimusTreatment OutcomeWilms TumorCyclosporineTacrolimusWT1 Proteins

Identifiers

PMID23302619
OpenAlexW2212846905

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.